UHS

Business profile & competitive position

Universal Health Services, Inc. is a holding company that owns and operates acute care hospitals, outpatient facilities, and behavioral health centers through subsidiaries. As of February 25, 2026, the company owned and/or operated 375 inpatient facilities and 168 outpatient or other facilities across 40 U.S. states, Washington, D.C., Puerto Rico, and the United Kingdom. Its hospitals provide a broad set of services including general and specialty surgery, internal medicine, obstetrics, emergency care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services, and behavioral health services. The company also supplies centralized management services such as purchasing, information services, finance and control systems, facilities planning, physician recruitment, marketing, and public relations.

The revenue mix is fairly balanced between the two major platforms. In both 2025 and 2024, acute-care-related streams contributed roughly 57% of consolidated net revenues, while behavioral-health-related streams contributed roughly 43%. With approximately 101,500 total employees, including about 88,100 in the U.S. and 13,400 in the U.K., and roughly 460 acute-care physicians and 445 behavioral-health physicians, UHS carries material operational scale in the Medical - Care Facilities industry.

The financial footprint suggests more than scale. The company reports a net margin of 8.4% and a return on equity of 20.7%. A 20.7% ROE indicates that management has historically generated a substantial return on the book equity invested, while the 8.4% net margin is a useful benchmark for how much of each revenue dollar converts to bottom-line profit. Those figures, combined with the diversified revenue base between acute and behavioral care, point to a business that has been able to convert large-scale facility operations into profitable outcomes, though margins in hospital services are always sensitive to payer mix, utilization, and labor costs.

Financial posture

UHS currently trades with a market capitalization of $10.3 billion and a price-to-earnings ratio of 6.9. That P/E sits well below typical growth-stock territory and, when measured against the 20.7% ROE, implies the market is applying a fairly compressed valuation to the company’s earnings power. The stock’s beta is 1.06, meaning its price volatility has historically tracked the broader equity market closely rather than showing either defensive or highly speculative movement.

The current share price is $170.33, compared with a 50-day exponential moving average of $165.67 and an RSI of 51.7. The RSI reading near the midpoint suggests neither overbought nor oversold momentum, while the price sitting above the 50-day EMA reflects near-term relative strength on a simple trend basis. Combined with the P/E multiple of 6.9 and the double-digit ROE, the valuation profile can be read as one where the market is pricing in significant pressure on future earnings, even as trailing profitability remains robust.

Strategic priorities & outlook

In its most recent SEC 10-K filing, Universal Health Services outlined a strategy built around selective expansion, portfolio optimization, and operating leverage at existing facilities. The company plans to grow by acquiring, constructing, or leasing hospital facilities, while divesting non-contributing assets. On the behavioral health side, it intends to partner with non-UHS acute care hospitals through facility purchases, leased beds, and joint ventures, a model that lets it deploy behavioral-health capacity without building every site from the ground up.

The operational goals also center on improving revenues and profitability at existing hospitals by introducing new or improved services, recruiting physicians, and tightening financial and operational controls. Outpatient services are a stated expansion area, supported by efficiency programs covering staffing, equipment usage, patient management, billing, and collections. Quality-care maintenance is listed as a guardrail rather than a trade-off. Physician recruitment and provider-network development are described as aggressive priorities, with innovation framed as a response to regulatory trends and market changes. This collection of priorities signals a management focus that combines physical expansion, same-facility improvements, and cost discipline.

Macro & geopolitical exposure

As a Healthcare sector name in the Medical - Care Facilities industry, UHS is exposed to a set of macro and policy variables that broadly affect hospital operators. Reimbursement policy is the first and largest exposure, because Medicare, Medicaid, and commercial insurance rates directly influence revenue per admission and per procedure. Changes to federal or state healthcare spending, site-of-service rules, or out-of-network billing regulations can shift profitability quickly.

Labor markets are another macro channel. Physician and nursing shortages, wage inflation, and contract labor costs have historically been significant pressure points for acute and behavioral care operators. Supply chain exposure matters as well, since medical equipment, pharmaceuticals, and personal protective goods can be affected by trade policy, tariffs, and global shipping constraints. Energy and utility costs also flow directly through the income statement for a facility-heavy operator that must maintain climate control, sterilization, and around-the-clock service.

The company’s U.K. footprint adds currency exposure, because roughly $1.001 billion of 2025 net revenues and $1.531 billion in total assets are tied to British behavioral health operations. GBP/USD movements and U.K. healthcare policy therefore represent genuine, if secondary, variables for a predominantly U.S. business. Finally, interest-rate conditions affect capital access for the acquisitions, construction, and leasing programs listed in the 10-K priorities.

Recent developments

August 2026 brought a cluster of UHS-related headlines that highlight valuation debate and post-earnings price action. On August 20, Zacks published “Universal Health Shares Drop 21% YTD: Should You Buy Now?,” flagging the year-to-date decline that had already occurred heading into the final third of the year. Six days later, on August 26, the same outlet ran “Why Is Universal Health Services (UHS) Up 5.7% Since Last Earnings Report?,” pointing to a rebound tied to the company’s July 27 earnings release. On August 25, PRNewswire reported that Universal Health Services, Inc. will present at September healthcare conferences, a routine but notable investor-relations event that can bring renewed institutional attention.

Perhaps the most analytically focused headline came on August 27, when Seeking Alpha published “The Pricing Power Prescription: Unlocking Universal Health Services' Hidden Fair Value.” Taken together, the August news flow shows a stock that had already declined materially on the year, recovered somewhat after its most recent earnings report, and is now drawing valuation commentary ahead of fall healthcare conferences.

Earnings behavior & post-earnings drift

UHS has delivered a strong earnings track record over the last eight reported quarters, beating the unofficial consensus in seven of those eight quarters, for an 88% beat rate. The average earnings surprise across that span is 8.1%. Yet the market’s behavior after these reports is more nuanced than the beat rate alone would suggest. The average five-trading-day price move following earnings, across those eight quarters, is -2.64%, classified as a downward post-earnings drift. That means even when results exceed estimates, the stock has more often than not given back ground in the days that follow.

Looking at the four most recent reports, the pattern becomes visible. On October 27, 2025, UHS reported EPS of $5.69 against an estimate of $4.66, a 22.1% surprise, and the stock rose 2.47% the next day and 3.12% over the next five days. On February 25, 2026, the company posted $5.88 versus the $5.92 estimate, a -0.7% miss, and the stock fell 11.44% the next session and 12.32% over the following five days. On April 27, 2026, UHS beat with $5.62 against $5.41, a 3.9% surprise, yet the stock dropped 9.45% the next day and 7.49% over the next five days. Most recently, on July 27, 2026, the company reported $5.98 versus $5.94, a 0.7% beat, and the stock rose 4.34% the next day and 6.11% over the next five days.

That quarterly history shows both the reporting consistency and the post-event volatility. The next scheduled report is October 26, 2026, after the market close, with the official consensus EPS estimate at $5.23. Traders watching the stock into that date should be aware that the company’s earnings results have frequently beaten the unofficial consensus, but that the subsequent price reaction has not always rewarded that outperformance.

For a deeper dive into how institutional analysts currently assess Universal Health Services—covering detailed valuation models, forward estimates, and the full range of rating actions—readers should examine the complete institutional verdict on the stock.